Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) belong to the family of perfluorinated compounds (PFCs). They are used in industrial and consumer applications, e.g. clothing fabrics, carpets and food packaging. PFOS and PFOA are present in the environment and are found in dust and human milk, which implies that newborns and toddlers can be directly exposed to these agents during brain development. Recently, we reported that PFOS and PFOA can cause neurobehavioral defects and changes in the cholinergic system, in the adult animal, when given directly to neonatal mice, and thereby showing similarities with other investigated persistent organic pollutants (POPs), such as DDT, polychlorinated biphenyls (PCBs), and polybrominated diphenyl ethers (PBDEs). In recent studies, we have also seen that highly brominated PBDEs can affect the levels of proteins that are important for neuronal growth and synaptogenesis in the neonatal mouse brain. The present study shows that a single oral dose of either 21 µmol PFOS or PFOA/kg body weight (11.3 mg or 8.70 mg), given directly to the neonatal mice on postnatal day 10, significantly increased the levels of CaMKII, GAP-43, and synaptophysin in the hippocampus of the neonatal mouse. Both compounds significantly increased the levels of synaptophysin and tau in cerebral cortex and PFOA also increased the levels of tau in hippocampus. Since these proteins are important for normal brain development and altered levels of these proteins during a critical period of the brain growth spurts (BGS) could be one of the mechanisms behind earlier reported behavioral defects.
INTRODUCTION
implies direct exposure to these agents during a period of rapid brain development in newborns and toddlers.
In a previous study, we showed that neonatal exposure to PFOS and PFOA during a period of rapid brain development can cause neurotoxic effects in adult mice, manifested as changes in spontaneous behavior, habituation, and altered susceptibility of the cholinergic system (Johansson et al. 2008a) . In other studies, we have also shown that this period of rapid brain development is vulnerable to insult by xenobiotics (bioallethrin, DDT, nicotine, ketamine, PBDE 99, and PBDE 209) and that the presence of the compound in the brain during a defined period of this maturational process is a critical factor (Ahlbom et al. 1994; Eriksson et al. 1992; Eriksson et al. 2000; Eriksson et al. 2002; Viberg et al. 2003a Viberg et al. , 2007 Viberg et al. 2008a; Viberg et al. 2008b) . The doses of PFOS and PFOA were also in the same order of magnitude as those that caused behavioral changes for DDT and PBDEs. This period of rapid brain growth is known as the "brain growth spurt", or BGS (Davison and Dobbing 1968) .
This period in mammalian development is associated with numerous biochemical changes that transform the feto-neonatal brain into that of the mature adult. The BGS includes axonal and dendritical outgrowth, establishment of neuronal connections, synaptogenesis, and proliferation of glia cells with accompanying myelinization (Davison and Dobbing 1968; Kolb and Whishaw 1989) . The BGS varies in onset and duration between species. In rats and mice, the BGS occurs in the neonate, spanning the first 3-4 weeks of life and peaking around postnatal day 10 (PND 10). In humans, it begins during the third trimester of pregnancy and continues throughout the first two years of life, coinciding with the lactation period.
During the BGS, the levels of several proteins involved in neuronal survival, growth, and synaptogenesis change. Among them are calcium/calmodulin-dependent protein kinase II (CaMKII), growth associated protein-43 (GAP-43), synaptophysin, and tau. The function of CaMKII involves regulation of synapotogenesis and synaptic plasticity (Frankland et al. 2001; Rongo and Kaplan 1999) . GAP-43 plays a key role in guiding the growth of axons and modulating the information of new connections. Due to its characteristics and pattern of expression, GAP-43 is frequently used as a marker for axonal sprouting and growth (Oestreicher et al. 1997) . Synaptophysin is an integral membrane glycoprotein in presynaptic vesicles and is localized in all nervous tissue (Navone et al. 1986; Wiedenmann and Franke 1985) . Synaptophysin has also been identified as a useful marker for synaptic density (Hamos et al. 1989; Masliah et al. 1990) . Tau, which is a microtubule-associated protein, has been implicated in the outgrowth of neuronal processes, the development of neuronal polarity, and the maintenance of normal morphology of the neurons, as reviewed by (Wang and Liu 2008) , as well as in the promotion of microtubule assembly and the maintainance of stability (Weingarten et al. 1975; Vila-Ortiz et al. 2001) . We have recently reported that the levels of these proteins increase during the BGS in the neonatal mouse, with the most pronounced increase taking place around PND 7-14 (Viberg submitted) (Viberg et al. 2008a ).
We have seen in an earlier study that neonatal exposure to PFOS and PFOA can cause developmental neurotoxic effects, manifested as defect spontaneous behavior and habituation as well as dysfunction of the cholinergic system when given during the critical period of neonatal brain development in mice. These behavioral defects are similar to those seen after neonatal exposure to the highly brominated diphenyl ethers (Johansson et al. 2008b; Viberg et al. 2003b; Viberg et al. 2006) . Recently, we have also shown that PBDE 209 affects the levels of CaMKII and GAP-43 (Viberg et al. 2008a) . Therefore, the present study was undertaken to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 investigate whether neonatal exposure to PFOS or PFOA can affect the protein levels of CaMKII, GAP-43, synaptophysin, and tau in the neonatal mouse brain.
MATERIALS AND METHODS

Chemicals and animals
Pregnant NMRI (Naval Medical Research Institute) mice were obtained from B&K, Sollentuna, Sweden and were housed individually in plastic cages in a room with an ambient temperature of 22°C and a normal 12/12 hr cycle of light and dark. The animals were supplied with standardized pellet food (Lactamin, Stockholm, Sweden) and tap water ad libitum. The pregnant NMRI mice were checked for birth twice daily (08.00 and 18.00 hr). The day of birth was designated day 0 and pups born during the night were designated day 0 when checked at 08.00 hr. The size of the litters was adjusted to 10-12 mice within the first 48 hr after birth by euthanizing excess pups. The litters contained pups of both sexes, in about equal numbers. Only male mice were used in order to compare with our earlier developmental neurotoxicological study on PFOS and PFOA (Johansson et al. 2008a) Perfluorooctane sulfonate (PFOS, potassium salt, purity ≥ 98%) and perfluorooctanoic acid (PFOA, purity = 96%) were purchased from Sigma-Aldrich. The substances were dissolved in a mixture of egg lecithin (Merck, Darmstadt, Germany) and peanut oil (Oleum arachidis)
(1:10) and then sonicated together with water to yield a 20% (w:w) fat emulsion vehicle containing 1.13 mg PFOS/ml or 0.870 mg PFOA/ml (2.1 µmol/ml, respectively). The use of a 20% fat emulsion vehicle was to give a more physiologically appropriate absorption and hence distribution (Keller and Yeary 1980; Palin et al. 1982) , since fat content of mouse milk is around 14%.
At the age of 10 days, mice were exposed to a single oral dose of either 21 µmol PFOS/kg body weight (11.3 mg/kg body weight) or 21 µmol PFOA/kg body weight (8.70 mg/kg body weight) via a metal gastric-tube. In the same manner, the control animals received 10 ml/kg body weight of the 20% fat emulsion vehicle. The number of litters in each treatment group was as follows: controls 3 litters, PFOS 4 litters, PFOA 4 litters. Brain tissues from 7 to 8 animals were used in the protein analysis. The animals were sacrificed by decapitation 24 hr after exposure to the vehicle, PFOS or PFOA (i.e., on PND 11) and the brains were dissected on an ice-cold glass plate. The cortex and hippocampus were collected and frozen at -80°C until assayed.
Slot-blot analysis for CaMKІІ, GAP-43, synaptophysin, and tau Cerebral cortex and hippocampus were homogenized in a RIPA cell lysis buffer (50 mM Tris HCL, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 20 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 1% sodium deoxycholate) with the addition of 0.5% protease inhibitor cocktail (Protease Inhibitor Cocktail set ІІІ, Calbiochem). The homogenate was then centrifuged at 14,000 × g for 15 min at 4°C, and the protein content of the supernatant was measured using the BCA method (Pierce). Subsequently, the supernatant was stored at -80°C until use.
An evaluation of the antibodies used was earlier conducted by Viberg et al. by running the
synaptophysin (Calbiochem 573822), and tau (Santa Cruz Biotechnology 32274) (Viberg submitted) antibodies in a Western blot procedure, which showed that the antibodies were specific for the protein intended. It was thus concluded that the antibodies were suitable for use in the slot blotting procedure. The four antibodies recognize both the non-phosphorylated and phosphorylated form of the protein.
Four µg of protein for CaMKII and GAP-43, 3µg for synaptophysin, and 3.5 µg for tau were diluted to a final volume of 200 µl with sample buffer (120 mM KCl, 20 mM NaCl, 2 mM NaHCO 3 , 2 mMMgCl 2 , 5 mM HEPES, pH 7.4, 0.05% Tween-20, 0.2% NaN 3 ) and applied in duplicates to a nitrocellulose membrane (0.45 µm, Bio-Rad) using a Bio-Dot SF microfiltration apparatus (Bio Rad). The membranes were fixed in 25% isopropanol and 10% acetic acid solution, washed, and blocked for 1 hr at room temperature in 5% non-fat dry milk containing 0.03% Tween-20. The membranes were then incubated overnight at 4°C with a mouse monoclonal CaMKІІ antibody (1:5,000), a rabbit polyclonal GAP-43 antibody
(1:10,000), a mouse monoclonal synaptophysin antibody (1:10,000), or a mouse monoclonal tau antibody (1:1,000). Immunoreactivity was detected using a horseradish peroxidase- conjugate secondary antibody against mouse (074-1806, 1:20,000) or rabbit (KPL 074-1506, 1:20,000). Immunoreactive bands were detected using an enhanced chemiluminescent substrate (Pierce, Super Signal West Dura) with imaging on a LAS-1000 (Fuji Film, Tokyo, Japan). The intensity of bands was quantified using IR-LAS 1000 Pro (Fuji Film).
Statistical analysis
The body weight data from 10-and 11-day-old mice were subjected to one-way ANOVA and pairwise testing using Newman-Keuls post hoc test (GraphPad Prism 5.01, GraphPad Software, San Diego, CA, USA). Differences between CaMKII, GAP-43, synaptophysin, and tau protein levels in vehicle-, PFOS-, and PFOA-treated animals were determined using oneway ANOVA. Pairwise testing between the different treatment groups was performed with Newman-Keuls post hoc test (GraphPad Prism 5.01).
RESULTS
There were no overt signs of acute toxic effects in the PFOS-and PFOA-treated mice. The body weights (mean ± S.D.) of the 10-day-old mice did not differ significantly (P > 0.05) between the vehicle-treated (6.09 ± 0.51 g), PFOS-treated (5.75 ± 0.51 g), and PFOA-treated (6.15 ± 0.31 g). Nor were there any significant (P > 0.05) differences between the vehicletreated (6.45 ± 0.42 g), PFOS-treated (6.20 ± 0.56 g), and PFOA-treated (6.56 ± 0.29 g) in 11-day-old mice. This shows that there were no acute effects on the body weights. The body weights for 10-day-old mice are in accordance with our earlier study on developmental toxicity study on PFOS and PFOA (Johansson et al. 2008a ). 
Effects on GAP-43 protein levels
There were significant treatment effects on GAP-43 levels in the hippocampus [ with PFOS, the synaptophysin levels in the hippocampus were significantly increased (P < 0.001) by 48% and in cerebral cortex (P < 0.01) by 59%, compared to vehicle-treated mice. In
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Effects on tau protein levels
There were significant treatment effects on tau levels in the hippocampus [F 2, 20 = 4.40, P = 0.0261] and in cerebral cortex [F 2, 14 = 7.459, P = 0.0062], Fig. 4 . In mice treated with PFOS, the tau levels were not significantly different (P > 0.05) in the hippocampus, but significantly increased (P < 0.05) in cerebral cortex by 80%, compared to vehicle-treated mice. In addition, tau levels in the hippocampus were significantly increased (P < 0.05) by 92% and in cerebral cortex (P < 0.01) by 142% in mice treated with PFOA, compared to vehicle-treated mice.
DISCUSSION
We have recently reported that neonatal exposure to PFOS and PFOA during the BGS on PND 10 caused deranged spontaneous behavior, manifested as reduced and/or lack of habituation and hyperactivity, and had effects on the cholinergic system in the adult mice (Johansson et al. 2008a) . These effects were dose-related, exacerbated with age, and occurred in the absence of any overt clinical signs of toxicity and without any change in body weight and body weight gain. The present study shows that administration of 21 µmol PFOS or 21 µmol PFOA/kg body weight to mice on PND 10 alters the amount of CaMKII, GAP-43, synaptophysin, and tau in the neonatal brain. Neonatal exposure to PFOS and PFOA on PND 10 significantly increased the levels of CaMKII, GAP-43, and synaptophysin in the hippocampus. Increased levels of synaptophysin and tau were also seen in the cerebral cortex in mice after neonatal exposure to PFOS and PFOA. In addition, mice exposed to PFOA showed significantly increased levels of tau in the hippocampus. This indicates that the hippocampus is the most sensitive brain region investigated for neurotoxic effects of neonatal PFOS and PFOA exposure. Whether these regional differences in the effects of neonatal exposure to PFOS and PFOA could result from differences in the developmental processes in the hippocampus and cerebral cortex, or whether it is the amounts of the compounds reaching the hippocampus and cerebral cortex that are different, is not clear. During the BGS in mice, there is dramatic change in the protein levels of CaMKII, GAP-43, synaptophysin, and tau (Viberg submitted) (Viberg et al. 2008a ).
In the case of CaMKII, the greatest rate of increase is in the amount seen between PND 7 and PND 14 (Viberg et al. 2008a). The ontogeny of CaMKII is almost the same in the two brain regions. It has also been reported, in rats, that the expression of CaMKII increased continuously during the first four weeks of life and that this increase was similar in the hippocampus and cerebral cortex (Kelly et al. 1987; Polli et al. 1990; Sugiura and Yamauchi 1992) . GAP-43, on the other hand, has a bell-shaped ontogeny, with peak levels around PND 7 in the hippocampus, whereas the peak is around PND 10 in cerebral cortex (Viberg et al. 2008a ). In the case of synaptophysin, the levels increase most rapidly in the hippocampus and cerebral cortex between PND 10 and PND 14 and continue to increase at least up to PND 28 (Viberg submitted). The ontogeny of tau reaches a peak in the hippocampus and cerebral cortex at PND 3 and PND 7, respectively, and thereafter declines (Viberg submitted). This shows that the ontogenies of the respective proteins are quite similar in the hippocampus and the cerebral cortex. Therefore, the observed increased levels of CaMKII, GAP-43, synaptophysin, and tau in the PFOS-and PFOA-treated animals do not seem to be connected 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 to the different developmental phases of these proteins in the two different brain regions. The increased levels of these proteins during the BGS in animals neonatally exposed to PFOS or PFOA might have consequences for normal brain development, with effects on the final architecture and function of the hippocampus and cerebral cortex. An increase in the amount of CaMKII protein, as seen in the hippocampus in mice exposed to PFOS or PFOA, can affect normal synaptogenesis as well as synaptic plasticity, since CaMKII is involved in those events (Frankland et al. 2001; Rongo and Kaplan 1999) . Although there is limited information on the effects of developmental neurotoxicants on CaMKII, neonatal exposure to PBDE 209, PBDE 206, PBDE 203, and ketamine has been shown to increase the CaMKII protein level in the hippocampus (Viberg submitted) (Viberg et al. 2008a; Viberg et al. 2008b) . Recently, a study concluded that neonatal exposure to PBDE 47 on PND 10 affected hippocampal LTP and decreased the phosphorylated (active) form of CaMKII (Dingemans et al. 2007 ). The function of synaptophysin is not fully understood but synaptophysin is involved in synapse formation and synaptic plasticity, and an imbalance in the synaptophysin level might affect the long-term development of the brain in ways that could result in functional impairments later in life (Janz et al. 1999; Tarsa and Goda 2002) . It is known that synaptophysin is activated by CaMKII phosphorylation on synaptophysin (Lynch 2004) , which may play an important role in long-term potentiation. It has been reported that depletion of GAP-43 markedly prevents neurite and growth cones formation and that over-expression on the other hand results in excessive sprouting . It is worth noting that these proteins are affected after neonatal exposure to PFOA, PBDE 203, 206, 209,  and ketamine, at doses where we have observed functional impairments in adult mice (Fredriksson and Archer 2004; Fredriksson et al. 2007; Johansson et al. 2008a; Johansson et al. 2008b; Viberg et al. 2003b; Viberg et al. 2006 ).
In humans, the developing brain is inherently much more susceptible (Davison and Dobbing 1968 ), which appears to include greater susceptibility to injury from toxic agents than the brain of an adult person (Grandjean and Landrigan 2006) . It is known that if a developmental process in the brain is halted or inhibited, there is only a slight potential for subsequent repair, and the consequences can therefore be permanent (Davison and Dobbing 1968; Rice and Barone 2000) . In our earlier study, we observed that neonatal exposure to PFOS and PFOA led to persistent disturbances in the cholinergic system and to disturbed behavior in the adult animal (Johansson et al. 2008a) . During the BGS, parallel with the development of CaMKII, GAP-43, synaptophysin, and tau, the ontogeny of the cholinergic system is taking place. In mice, the levels at birth of choline acetyltransferase (ChAT), acetylcholinesterase (AChE), muscarinic acetylcholine receptors (mAChRs), and nicotinic acetylcholine receptors (nAChRs) are about 20% of the adult amount, but adult levels are reached within 3-4 weeks (Coyle and Yamamura 1976; Falkeborn et al. 1983; Fiedler et al. 1987; Kuhar et al. 1980) .
We have seen in earlier studies that PBDEs affect behavior in a similar way as PFOS and PFOA do. Furthermore, the cholinergic system has been affected, manifested as an altered response to the cholinergic agent (nicotine) and reduced amount of muscarinic (Viberg et al. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 2005) and nicotinic receptors (Viberg et al. 2003a; Viberg et al. 2004) in the hippocampus at adult age, and that such receptors can be affected as early as during neonatal development which have been observed after exposure to certain environmental toxicants such as DDT, pyrethroids and nicotine (Ahlbom et al. 1994; Eriksson 1992; Eriksson et al. 2000) .
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Whether early changes in CaMKII, GAP-43, synaptophysin, and tau, with possible consequences on behavior (learning and memory, cognitive functions) and the cholinergic system, can affect normal development is an intriguing question. . In AD, the neuropathological hallmarks are senile plaques and neurofibrillary tangles. The pathogenic peptide β-amyloid 42 has been shown to induce hyperphosphorylation of tau and that this may impair the function and plasticity of the synapse. This malfunction is thought to be one of many possible abnormalities linked to AD (Muntane et al. 2008; Wang et al. 2003) . Other processes that play a crucial role in AD pathology include formation of tau and neurotransmitter impairment (Mattson 2004) . With elevated levels of tau in the brain at neonatal age, as seen in the present study in mice exposed to PFOS or PFOA, and an altered response of the cholinergic system in adult mice neonatally exposed to the same compounds (Johansson et al. 2008a) , it is possible that early exposure to certain PFCs can affect processes linked to neurodegeneration, with consequences for cognitive function. In conclusion, the present study shows that the levels of four proteins, CaMKII, GAP-43, synaptophysin, and tau, are affected in the brain 24 h after neonatal exposure to PFOS or PFOA on PND 10, and that the hippocampus may be one of the main target regions in the brain. All four proteins are known biochemical substrates for cellular processes like neurite outgrowth and synaptogenesis, and altered levels of these proteins may alter normal brain development. With regard to our earlier study on developmental neurotoxic effects of PFOS and PFOA (Johansson et al. 2008a) , the interaction between the studied proteins and the development of the cholinergic system in the hippocampus may help explain the effects on adult behavior and an altered response of the cholinergic system. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Viberg, H., Fredriksson, A., and Eriksson, P. (2003a) . Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice. Toxicology and applied pharmacology 192, 95-106.
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